Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells

Cellular Immunology

Volumn 277, Issue 1-2, 2012, Pages 66-73

  Liu, Lu ^a   Li, Lin ^a   Min, Jun ^a   Wang, Jie ^a   Wu, Heng ^a   Zeng, Yujie ^a   Chen, Shuang ^a   Chu, Zhonghua ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Butyrate; Dendritic cell; Immunosuppression

Indexed keywords

B7 ANTIGEN; BUTYRIC ACID; CD83 ANTIGEN; CELL SURFACE MARKER; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL MATURATION; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; DRUG ACTIVITY; ENDOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD80; BUTYRATES; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DOWN-REGULATION; ENDOCYTOSIS; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULINS; IMMUNOSUPPRESSION; MEMBRANE GLYCOPROTEINS; MONOCYTES;

EID: 84864324829     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.05.011     Document Type: Article

References (38)

1. Mayer W.J., Irschick U.M., Moser P., Wurm M., Huemer H.P., Romani N., Irschick E.U. Characterization of antigen-presenting cells in fresh and cultured human corneas using novel dendritic cell markers. Invest. Ophthalmol. Vis. Sci. 2007, 48:4459-4467.
2. Bros M., Jährling F., Renzing A., Wiechmann N., Dang N.A., Sutter A., Ross R., Knop J., Sudowe S., Reske-Kunz A.B. A newly established murine immature dendritic cell line can be differentiated into a mature state, but exerts tolerogenic function upon maturation in the presence of glucocorticoid. Blood 2007, 109:3820-3829.
3. Barratt-Boyes S.M., Thomson A.W. Dendritic cells: tools and targets for transplant tolerance. Am. J. Transplant. 2005, 5:2807-2813.
4. Rober L., Wan F.N., Ralph M.S. Dendritic cells in transplantation - friend or foe. Immunity 2001, 14:357-368.
5. Tochiki N., Narita M., Zheng Z., Lu C., Saitoh A., Watanabe N., Satoh N., Furukawa T., Toba K., Fuse I., Aizawa Y., Takahashi M. Induction of recipient cell-specific donor T-cell anergy by UV-C-irradiated recipient immature monocyte-derived dendritic cells. Bone Marrow Transplant. 2008, 41:1037-1045.
6. Ikeda Y., Akbar F., Matsui H., Onji M. Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 2001, 13:841-850.
7. Coates P.T., Duncan F.J., Colvin B.L., Wang Z., Zahorchak A.F., Shufesky W.J., Morelli A.E., Thomson A.W. In vivo-mobilized kidney dendritic cells are functionally immature, subvert alloreactive T-cell responses, and prolong organ allograft survival. Transplantation 2004, 77:1080-1089.
8. Geissmann F., Revy P., Regnault A., Lepelletier Y., Dy M., Brousse N., Amigorena S., Hermine O., Durandy A. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J. Immunol. 1999, 162:4567-4575.
9. Lutz M.B., Suri R.M., Niimi M., Ogilvie A.L., Kukutsch N.A., Rössner S., Schuler G., Austyn J.M. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur. J. Immunol. 2000, 30:1813-1822.
10. Zheng Z., Narita M., Takahashi M., Liu A., Furukawa T., Toba K., Aizawa Y. Induction of T cell anergy by the treatment with IL-10-treated dendritic cells. Comp. Immunol. Microbiol. Infect. Dis. 2004, 27:93-103.
11. Gorczynski R.M., Bransom J., Cattral M., Huang X., Lei J., Xiaorong L., Min W.P., Wan Y., Gauldie J. Synergy in induction of increased renal allograft survival after portal vein infusion of dendritic cells transduced to express TGF-β and IL-10, along with administration of CHO cells expressing the regulatory molecule OX2. Clin. Immunol. 2000, 95:182-189.
12. Cignetti A., Vallario A., Roato I., Circosta P., Allione B., Casorzo L., Ghia P., Caligaris-Cappio F. Leukemia-derived immature dendritic cells differentiate into functionally competent mature dendritic cells that efficiently stimulate T cell responses. J. Immunol. 2004, 173:2855-2865.
13. Wang L., Luo H.S., Xia H. Sodium butyrate induces human colon carcinoma HT-29 cell apoptosis through a mitochondrial pathway. J. Int. Med. Res. 2009, 37:803-811.
14. Liang G., Taranova O., Xia K., Zhang Y. Butyrate promotes induced pluripotent stem cell generation. J. Biol. Chem. 2010, 285:25516-25521.
15. Jackson S.K., DeLoose A., Gilbert K.M. The ability of antigen, but not interleukin-2, to promote n-butyrate-induced T helper 1 cell anergy is associated with increased expression and altered association patterns of cyclin-dependent kinase inhibitors. Immunology 2003, 106:486-495.
16. Gilbert K.M., Boger S.R., Price P., Fifer E.K. T cell tolerance induced by histone deacetylase inhibitor is mediated by P21cip1. Immunopharmacol. Immunotoxicol. 2005, 27:545-564.
17. Joachimiak R., Kaznica A., Drewa T. Influence of sodium butyrate on hepatocellular carcinoma (hepG2) and glioblastoma (C6) cell lines in vitro. Acta Pol. Pharm. 2007, 64:561-563.
18. Zhou M., Li P., Tan L., Qu S., Ying Q.L., Song H. Differentiation of mouse embryonic stem cells into hepatocytes induced by a combination of cytokines and sodium butyrate. J. Cell. Biochem. 2010, 109:606-614.
19. Zhou L.J., Tedder T.F. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 1995, 154:3821-3835.
20. Mondino A., Jenkins M.K. Surface proteins involved in T cell costimulation. J. Leukoc. Biol. 1994, 55:805-815.
21. Wang B., Morinobu A., Horiuchi M., Liu J., Kumagai S S. Butyrate inhibits functional differentiation of human monocyte-derived dendritic cells. Cell. Immunol. 2008, 253:54-58.
22. Säemann M.D., Parolini O., Böhmig G.A., Kelemen P., Krieger P.M., Neumuller J., Knarr K., Kammlander W., Horl W.H., Diakos C., Stuhlmeier K., Zlabinger G.J. Bacterial metabolite interference with maturation of human monocyte-derived dendritic cells. J. Leukoc. Biol. 2002, 71:238-246.
23. Hathcock K.S., Laszlo G., Pucillo C., Linsley P., Hodes R.J. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 1994, 180:631-640.
24. Salek-Ardakani S., Arens R., Flynn R., Sette A., Schoenberger S.P., Croft M. Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells. J. Immunol. 2009, 182:2909-2918.
25. Matulonis U., Dosiou C., Freeman G., Lamont C., Mauch P., Nadler L.M., Griffin J.D. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct. J. Immunol. 1996, 156:1126-1131.
26. Rajavelu P., Das S.D. Expression of co-stimulatory molecules B7.1 & B7.2 on macrophages infected with various strains of Mycobacterium tuberculosis & its influence on T-cell apoptosis Indian. J. Med. Res. 2008, 127:388-394.
27. Bohmig G.A., Krieger P.M., Saemann M.D., Wenhardt C., Pohanka E., Zlabinger G.J. N-butyrate downregulates the stimulatory function of peripheral blood-derived antigen-presenting cells: a potential mechanism for modulating T-cell responses by short-chain fatty acids. Immunology 1997, 92:234-243.
28. Gruber A., Brocker T. MHC class I-positive dendritic cells (DC) control CD8 T cell homeostasis in vivo: T cell lymphopenia as a prerequisite for DC-mediated homeostatic proliferation of naive CD8 T cells. J. Immunol. 2005, 175:201-206.
29. Tseng S.Y., Otsuji M., Gorski K., Huang X., Slansky J.E., Pai S.I., Shalabi A., Shin T., Pardoll D.M., Tsuchiya H. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 2001, 193:839-846.
30. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996, 62:659-665.
31. Lu L., McCaslin D., Starzl T.E., Thomson A.W. Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 1995, 60:1539-1545.
32. Miro F., Nobile C., Blanchard N., Lind M., Filipe-Santos O., Fieschi C., Chapgier A., Vogt G., de Beaucoudrey L., Kumararatne D.S., Le Deist F., Casanova J.A., Amigorena S., Hivroz C. T cell-dependent activation of dendritic cells requires IL-12 and IFN-gamma signaling in T cells. J. Immunol. 2006, 177:3625-3634.
33. Messmer D., Hatsukari I., Hitosugi N., Schmidt-Wolf I.G., Singhal P.C. Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation. Mol. Med. 2006, 12:284-290.
34. Millard A.L., Mertes P.M., Ittelet D., Villard F., Jeannesson P., Bernard J. Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clin. Exp. Immunol. 2002, 130:245-255.
35. Peguet-Navarro J., Moulon C., Caux C., Dalbiez-Gauthier C., Banchereau J., Schmitt D. Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells. Eur. J. Immunol. 1994, 24:884-891.
36. Stax A.M., Crul C., Kamerling S.W., Schlagwein N., van der Geest R.N., Woltman A.M., van Kooten C. CD40L stimulation of rat dendritic cells specifically favors the IL-12/IL-10 ratio resulting in a strong T cell stimulatory capacity. Mol. Immunol. 2008, 45:2641-2650.
37. Toyokawa H., Nakao A., Bailey R.J., Nalesnik M.A., Kaizu T., Lemoine J.L., Ikeda A., Tomiyama K., Papworth G.D., Huang L., Demetris A.J., Starzl T.E., Murase N. Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation. Liver Transpl. 2008, 14:346-357.
38. Nouri-Shirazi M., Guinet E. Direct and indirect cross-tolerance of alloreactive T cells by dendritic cells retained in the immature stage. Transplantation 2002, 74:1035-1044.